Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.9%

5 terminated/withdrawn out of 63 trials

Success Rate

87.8%

+1.3% vs industry average

Late-Stage Pipeline

52%

33 trials in Phase 3/4

Results Transparency

3%

1 of 36 completed trials have results

Key Signals

6 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
18(34.0%)
Phase 3
15(28.3%)
N/A
14(26.4%)
Phase 2
5(9.4%)
Phase 1
1(1.9%)
53Total
Phase 4(18)
Phase 3(15)
N/A(14)
Phase 2(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (63)

Showing 20 of 63 trials
NCT05137119Phase 4Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial

Role: collaborator

NCT07060404Phase 2Not Yet Recruiting

Postpartum 8-aminoquinoline Breast Milk Study

Role: collaborator

NCT07060794Phase 4Not Yet Recruiting

Tafenoquine and ACTs (TADORE- Plus)

Role: lead

NCT07468513Phase 4Recruiting

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

Role: lead

NCT07468526Phase 3Not Yet Recruiting

An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria

Role: lead

NCT05879224Not ApplicableCompleted

Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia

Role: lead

NCT02783859Phase 4Completed

Hospitalised Pneumonia With Extended Treatment (HOPE) Study

Role: lead

NCT05874271Not ApplicableCompleted

Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea

Role: collaborator

NCT05690841Phase 3Recruiting

FocaL Mass Drug Administration for Vivax Malaria Elimination

Role: collaborator

NCT06148792Phase 3Recruiting

A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

Role: lead

NCT06259006Phase 3Recruiting

TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children

Role: collaborator

NCT06461429Not ApplicableNot Yet Recruiting

PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]

Role: collaborator

NCT05426434Phase 3Active Not Recruiting

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

Role: lead

NCT03916029Not ApplicableCompleted

Hearing for Learning Initiative - a Health Facilitator Model for Otitis Media

Role: lead

NCT04411836Phase 3Completed

Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

Role: lead

NCT04079621Phase 4Completed

Short Course Radical Cure of P. Vivax Malaria in Nepal

Role: lead

NCT06002243Not ApplicableNot Yet Recruiting

Non-Expert Acquisition & Remote Expert Review of Screening Echocardiography Images From Child Health & AnteNatal Clinics

Role: lead

NCT02793336Completed

Early Life Cohort in Papua Indonesia (ELIPI Study)

Role: lead

NCT03224052Completed

Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria

Role: lead

NCT00616304Phase 2Suspended

Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria

Role: lead